Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Antineoplastics > 7-Ethyl-10-hydroxycamptothecin for Sale > SN-38 (7-Ethyl-10-hydroxycamptothecin ) 98% yellow crystalline powder Xieli
SN-38 (7-Ethyl-10-hydroxycamptothecin ) 98% yellow crystalline powder  Xieli buy - large image1
SN-38 (7-Ethyl-10-hydroxycamptothecin ) 98% yellow crystalline powder  Xieli buy - image1

SN-38 (7-Ethyl-10-hydroxycamptothecin ) 98% yellow crystalline powder Xieli

2 Inquiries

Unit Price: Get Latest Price
CAS No.:

86639-52-3

Grade:

Pharmaceutical Grade

Content:

98%

Brand:

Xieli

Packaging:

according to customer requirement

Sample Available:

Yes

Price valid (until):

2023-04-01

Company Type:
Manufactory
Location:
China
Payment Terms:
TT against copy of documents,L/C
Average Lead Time:
15 days
Qualification:
Main Products:

dasatinib,ingenol mebutate,hesperidin,irinotecan HCL,erlotinib,nastrozole

  • Product Description

  • Seller Information

  • Inquiry History

  • Description
    ItemsSpecifications
    AppearanceYellow crystalline powder
    CAS86639-52-3
    Molecular FormulaC22H20N2O5
    Melting Point217 °C

      Introduction of SN-38

    SN-38 is a bioactive metabolite of irinotecan hydrochloride (CPT-11). SN-38 caused the strongest inhibition of DNA topoisomerase I, followed by CPT, and then CPT-11. CPT-11 dose dependently transferred the position of loose DNA in the direction of incision DNA, but SN-38 and CPT had no effect on the position of loose DNA. SN-38 inhibited DNA synthesis in a dose-dependent and time-dependent manner. The respective IC50 value of SN-38 is 0.077 μ m in DNA synthesis. The inhibitory effect of SN-38 on cellular RNA synthesis is less than that on DNA synthesis and it does not inhibit protein synthesis. SN-38 caused frequent DNA single strand breaks in P388 cells.


    About us

    Xieli Pharm was Founded in 1980's as professional manufacturer on oncology& Animal/botanical derivative APIs and CMO services, with cGMP\ EU GMP\ Japan GMP certified factory and independent R& D center. R& D team with rich experience in process development in R& D, process scale-up and production, and succeed to finish many CMO projects. RA team with rich experience for global registration. DMF including 17 products registered in 100+ countries and submission 500+ times. Irinotecan certificated with Japan GMP and EU GMP. Rutin and Troxerutin certificated with EU-GMP; CEP for Diosmin & Troxerutin& Irinotecan HCl& Gefitinib& Anastrozole. OEM for plant extracting and TCM Processing. CDMO for Process Development, Intermidate, APIs, Formulation and Clinic Study.

    ECHEMI Editorial Reference
    SN-38 is an active metabolite of the Topoisomerase I inhibitor Irinotecan. SN-38 inhibits DNA and RNA synthesis with IC50s of 0.077 and 1.3 μM, respectively.
    SN-38 is a member of the class of pyranoindolizinoquinolines that is (4S)-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14-dione bearing two additional ethyl substituents at positions 4 and 11 as well as two additional hydroxy substituents at positions 4 and 9. It is the active metabolite of irinotecan and is ~1000 times more active than irinotecan itself. It has a role as an apoptosis inducer, an EC 5.99.1.2 (DNA topoisomerase) inhibitor, a drug metabolite and an antineoplastic agent. It is a pyranoindolizinoquinoline, a delta-lactone, a tertiary alcohol and a member of phenols.|7-ethyl-10-hydroxycamptothecin (SN 38) is a liposomal formulation of the active metabolite of Irinotecan [DB00762], a chemotherapeutic pro-drug approved for the treatment of advanced colorectal cancer. SN 38 has been used in trials studying the treatment of Cancer, Advanced Solid Tumors, Small Cell Lung Cancer, Metastatic Colorectal Cancer, and Triple Negative Breast Cancer, among others.|A semisynthetic camptothecin derivative that inhibits DNA TOPOISOMERASE I to prevent nucleic acid synthesis during S PHASE. It is used as an antineoplastic agent for the treatment of COLORECTAL NEOPLASMS and PANCREATIC NEOPLASMS.

    Basic Info
    Product Name:

    7-Ethyl-10-hydroxycamptothecin

    Other Name:

    1H-Pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione,4,11-diethyl-4,9-dihydroxy-,(4S)-;1H-Pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione,4,11-diethyl-4,9-dihydroxy-,(S)-;(4S)-4,11-Diethyl-4,9-dihydroxy-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione;7-Ethyl-10-hydroxycamptothecin;SN 38 (pharmaceutical);SN 38;10-Hydroxy-7-ethylcamptothecin;7-Ethyl-10-hydroxy-20(S)-camptothecin;SN 38 lactone;(S)-SN 38;(19S)-10,19-Diethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.0[2,11].0[4,9].0[15,20]]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaene-14,18-dione;113015-38-6

    CAS No.:

    86639-52-3

    Molecular Formula:

    C22H20N2O5

    InChIKeys:

    InChIKey=FJHBVJOVLFPMQE-QFIPXVFZSA-N

    Molecular Weight:

    392.4

    Exact Mass:

    392.40

    EC Number:

    1592732-453-0

    UNII:

    0H43101T0J

    NSC Number:

    673596

    DSSTox ID:

    DTXSID4040399

    HScode:

    2942000000

    Categories:

    Antineoplastics

    Characteristics
    PSA:

    100

    XLogP3:

    1.4

    Appearance:

    light-yellow solid

    Density:

    1.5±0.1 g/cm3

    Melting Point:

    217 °C

    Boiling Point:

    810.3°C at 760 mmHg

    Flash Point:

    443.8±34.3 °C

    Refractive Index:

    1.738

    Water Solubility:

    DMSO: soluble 1mg/mL

    Storage Conditions:

    −20°C

    Hazard Identification

    Classification of the substance or mixture

    Acute toxicity - Category 3, Oral

    GHS label elements, including precautionary statements

    Pictogram(s)
    Signal word

    Danger

    Hazard statement(s)

    H301 Toxic if swallowed

    Precautionary statement(s)
    Prevention

    P264 Wash ... thoroughly after handling.

    P270 Do not eat, drink or smoke when using this product.

    Response

    P301+P316 IF SWALLOWED: Get emergency medical help immediately.

    P321 Specific treatment (see ... on this label).

    P330 Rinse mouth.

    Storage

    P405 Store locked up.

    Disposal

    P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Manufactory

    Main Products:

    dasatinib,ingenol mebutate,hesperidin,irinotecan HCL,erlotinib,nastrozole

    Location:

    NO.588, middle section of mudan avenue

    Payment Terms:

    TT against copy of documents,L/C

    Average lead Time:

    15 days

    Total Annual Revenue:

    Above $100 million

    Total Employees:

    501-1000

    Year of Establishment:

    1992

    Company Profile
    Xieli Pharm was founded in 1980's with cGMP\ EU GMP\ Japan GMP certified factory and independent R&D center. Irinotecan certificated with Japan GMP and EU GMP. Rutin and Troxerutin certificated with EU-GMP; CEP for Diosmin and Troxerutin OEM for plant extracting and TCM Processing CDMO for Process Development, Intermidate, APIs, Formulation and Clinic Study.
  • Inquiry History
    2 Inquiries
    Country Product Purchase Quantity Date Posted
    India

    7-Ethyl-10-Hydroxy CamptothecinTotal Synthesis Manufacturer(CAS No.130194-92-2 86639-52-3 119577-28-5)

    5 KG Jun 13, 2026
    India

    7 Ethyal 10 Hydroxycaptothecin

    100 KG May 23, 2024
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.